FDAnews Drug Daily Bulletin

ANORMED RECOMMENDS SHAREHOLDERS REJECT DISSIDENT SLATE OF DIRECTOR NOMINEES

March 28, 2006
A A

The Board of Directors of AnorMED Inc. has recommended that shareholders vote in favor of the AnorMED slate of director nominees and reject any slate of director nominees that may be proposed by a dissident group of shareholders, represented by The Baker Group, holding approximately 23 percent of the Company's shares.
CNW Group